Clinical Trials Browser

Ovarian Neoplasms, Postoperative Complications, Recurrence, Neoplasm, Residual

NCT07382505 2026-02-02

Prospective Cohort Study of Minimal Residual Disease(MRD) Testing for Early Recurrence Detection in Endometrial and Cervical Cancer

Not yet recruiting

600 enrolled

Gynecologic

Uterine Cervical Neoplasms, Uterine Neoplasms, Endometrial Neoplasms, Neoplasm, Residual

NCT04853017 2025-09-05

AMPLIFY-201

Phase 1 Completed

25 enrolled 15 charts

GastrointestinalGynecologicThoracic

Bile Duct Neoplasms, Carcinoma, Non-Small-Cell Lung, Colonic Neoplasms, Gallbladder Neoplasms, Ovarian Neoplasms, Rectal Neoplasms, Colorectal Neoplasms, Cholangiocarcinoma, Neoplasm, Residual

NCT05955079 2023-07-21

ctDNA-endo

Unknown

130 enrolled

Gynecologic

Endometrial Neoplasms, Neoplasm, Residual

NCT03788850 2020-08-27

FARDCC

Completed

397 enrolled

Gynecologic

Uterine Cervical Dysplasia, Neoplasm, Residual

NCT00551577 2007-10-31

PRIMOVAR-1

Phase 2 Unknown

100 enrolled

Gynecologic

Ovarian Neoplasms, Neoplasm, Residual

Clinical Trials

retroESGO ov1

Prospective Cohort Study of Minimal Residual Disease(MRD) Testing for Early Recurrence Detection in Endometrial and Cervical Cancer

AMPLIFY-201

ctDNA-endo

FARDCC

PRIMOVAR-1